Identifying biomarkers for congenital and limb girdle muscular dystrophies

  • Identifying biomarkers for congenital and limb girdle muscular dystrophies

    Professor Muntoni and his team are searching for biomarkers for monitoring the progression of congenital and limb girdle muscular dystrophies.

    Read more
  • Prof Darren Monckton

    Understanding the genetics of myotonic dystrophy type 1

    Professor Monckton and his team are investigating links between genetic changes and the symptoms of myotonic dystrophy type 1.

    Read more
  • Peter Zammit

    Generating a model of FSHD and testing a potential therapeutic approach

    Professor Zammit and his team at King’s College London are generating a mouse model that will allow a greater understanding of the genetics underlying facioscapulohumeral muscular dystrophy.

    Read more
  • Professor Wood in his lab, University of Oxford

    Developing a genetic therapy for spinal muscular atrophy

    Professor Matthew Wood and his team are developing ways of improving the delivery of a potential genetic therapy for spinal muscular atrophy.

    Read more
  • Understanding cell membrane changes in centronuclear myopathy and Charcot-Marie-Tooth disease

    Dr Andrew Shevchuk is studying cell membrane changes and how these functions are altered in centronuclear myopathy and Charcot-Marie-Tooth disease.

    Read more
  • Understanding muscle fibre death in Duchenne muscular dystrophy

    Professor Jenny Morgan and her team aim to better understand the mechanisms of muscle fibre death in Duchenne muscular dystrophy and investigate whether this process could be manipulated with therapeutic benefit.

    Read more
  • Prof Thomas Gillingwater

    Protecting motor neurones in spinal muscular atrophy

    Professor Tom Gillingwater and his team are investigating how certain populations of motor neurones survive while others are lost in spinal muscular atrophy (SMA).

    Read more
  • Dr Saverio Tedesco

    Developing a cell and gene-based therapy for Duchenne muscular dystrophy

    Dr Tedesco is developing a new therapeutic approach that has the potential to help boys with Duchenne muscular dystrophy, or Becker muscular dystrophy.

    Read more
  • Developing a therapeutic approach for collagen VI-related muscular dystrophy

    Professor Francesco Muntoni is developing a novel therapeutic approach for people with Ullrich muscular dystrophy caused by dominant mutations in one of the collagen VI genes.

    Read more
  • Prof David abbott

    Exploring the views of men with Duchenne muscular dystrophy on end-of-life care decision making

    In this project, Professor David Abbott from Bristol University will investigate the views of men with Duchenne muscular dystrophy about decision-making for end-of-life care.

    Read more
  • News

    Near you

    Find support and services in your area:

    Keep in touch